Atlas Trials

A Study of Oral Vismodegib for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)

Clinical trial NCT02168530 · WITHDRAWN

Trial details

NCT number
NCT02168530
Sponsor
Hoffmann-La Roche
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Idiopathic Pulmonary Fibrosis
Start date
2014-10-01
Primary completion
2017-01-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.